Patients were randomly allocated to receive subcutaneous injections of semaglutide 2.4 mg, semaglutide 1.0 mg, or placebo once a week for 68 weeks, along with lifestyle intervention
Tener dudas sobre el medicamento semaglutida y sus efectos secundarios es normal
In practical terms, this is unlikely to significantly impact the effectiveness of Pepto-Bismol for symptom relief, but it is a factor worth considering
Bringing necessary documentation is key when traveling internationally with semaglutide
These include: Nausea (the most common complaint, particularly in the first few weeks) Vomiting Diarrhoea or constipation Decreased appetite (which, while therapeutically desirable, can occasionally be excessive) Abdominal discomfort or bloating Injection-site reactions (such as redness, itching, or mild swelling at the injection site) Headache, dizziness, and fatigue , particularly during early treatment These effects are generally dose-dependent and tend to diminish as the body adjusts to the medication
TRIUMPH-4 showed higher discontinuation rates correlated with baseline BMI [2][10]